Nature Reviews Endocrinology

Papers
(The H4-Index of Nature Reviews Endocrinology is 58. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Exercise-induced plasma factors confer brain benefits771
Exposing skin to ultraviolet irradiation increases food intake in male individuals656
Author Correction: Adrenocortical stem cells in health and disease625
Immune cell population prevents weight regain602
Dexamethasone in patients with diabetes mellitus450
Memory of obesity stored in adipocytes417
Identification of genetic factors of type 2 diabetes mellitus risk in South Asian populations390
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead376
The challenges of assessing adiposity in a clinical setting268
Non-nutritive sweeteners — too sweet to be wholesome?261
Timed high-fat diet feeding restores small bowel circadian rhythms228
Effects of diet on atherosclerotic plaque development205
Limiting the use and misuse of liothyronine in hypothyroidism193
The role of DNA damage in diabetic complications177
Thyroid function and iodine intake: global recommendations and relevant dietary trends176
CNOT6L regulates hepatokine expression172
The gut microbiota in obesity and weight management: microbes as friends or foe?169
Ketosis improves muscle stem cell resilience165
Metabolite levels during the menstrual cycle163
Research in metabolic ageing — a tale of mice versus humans?154
Patients’ insights into diabetes insipidus146
mTORC1 is the central regulator in pancreatic β-cells144
Neurons in the diagonal band of Broca moderate food intake139
Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines133
Reply to ‘Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines’133
Reply to ‘Why the science on T3 and genomics is not settled’118
Obesity phenotypes: explaining the unexplained113
The interactions between energy homeostasis and neurovascular plasticity113
A pivotal year for NAFLD and NASH therapeutics110
Negative regulator of GDF15 signalling identified110
Fusion with blood vessel organoids supports pancreatic islet function109
Steroid hormones as modulators of anti-tumoural immunity108
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus107
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity106
Handle with care — interpretation, synthesis and dissemination of data on paracetamol in pregnancy103
Primary aldosteronism — a multidimensional syndrome97
New role for bone marrow adipocytes in obesity93
A role for phosphocreatine in adipose inflammation92
Genetic risk scores improve prediction of obesity in survivors of childhood cancer89
Language evolves — so can you87
New maps and new challenges in the post-genomic era82
RalA links obesity and mitochondrial dysfunction79
Urocortin 3 function in glucose metabolism79
A role for the kidney in metformin action78
Stem-cell derived pancreatic endoderm cells in the treatment of T1DM77
Bone and muscle crosstalk in ageing and disease74
Targeting the incretin system in obesity and type 2 diabetes mellitus74
Advances in incretin-based therapeutics for obesity71
GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus70
The metabolic mythos of ketones68
Inflammation-induced adrenal dysfunction67
Signals from the dorsal motor nucleus of the vagus promote jejunal fat absorption66
Luteal phase support in assisted reproductive technology65
Advances in basic biology and translation in islet research62
Progress in islet transplantation is more important than ever62
Untangling the pathways of SDHx loss of function59
Triggering puberty in primates: is it NPY?59
Endosomal trafficking in metabolic homeostasis and diseases59
0.57496213912964